Magnesium L-Threonate (Magtein): Brain Magnesium, Cognitive Aging & Memory — A Research-Backed Guide
⚡ 60-Second Summary
Magnesium L-threonate (marketed as Magtein, developed at MIT) is a patented form of magnesium bound to L-threonic acid, a metabolite of vitamin C. Unlike other magnesium forms, it is specifically designed to cross the blood-brain barrier, raising central nervous system magnesium concentrations more efficiently. This brain-targeting property makes it the only magnesium form with plausible, mechanism-supported evidence for cognitive benefits — but it also means it is a poor choice for general magnesium deficiency correction.
Key research: Strong animal data (Liu et al. 2010; Slutsky et al. 2010) showing improved synaptic density and memory in aged rodents. One human RCT (Slutsky et al. 2022, n=109) showing cognitive improvements over 12 weeks — promising but limited by size and conflict-of-interest considerations.
Dose: 2 g/day of the Magtein complex (3 capsules ~667 mg each), delivering ~144 mg elemental Mg. This elemental dose is too low to address general magnesium deficiency. Supplement the remainder of your magnesium RDA from food or a separate magnesium form.
What is magnesium L-threonate?
Magnesium L-threonate (MgT, commercially known as Magtein) is a patented form of magnesium developed at the Massachusetts Institute of Technology by Guosong Liu, Inna Slutsky, and colleagues. It is formed by binding magnesium to L-threonic acid, a four-carbon sugar acid produced in the body from the oxidative metabolism of vitamin C (ascorbic acid).
The key distinction from other magnesium forms is the ability of the L-threonate carrier to facilitate magnesium transport across the blood-brain barrier (BBB). Most magnesium forms (oxide, citrate, bisglycinate, malate) raise serum and intracellular magnesium effectively but have limited capacity to increase cerebrospinal fluid and brain parenchyma magnesium concentrations, because the BBB's tight junctions restrict passive diffusion of charged ions. L-threonate appears to leverage specific transport mechanisms that give it superior CNS penetrance.
Magnesium plays critical roles in the brain: it blocks the NMDA receptor channel at resting membrane potential (the "Mg block"), regulates synaptic plasticity, and maintains the structural integrity of dendritic spines. Age-related decline in brain magnesium has been proposed as a contributor to cognitive aging, and restoring it is the mechanistic rationale for Magtein supplementation.
Evidence-based benefits of magnesium L-threonate
1. Synaptic density and cognitive aging — animal models (strong)
Liu et al. (2010, published in Neuron) demonstrated in aged rats that magnesium L-threonate supplementation significantly increased cerebrospinal fluid magnesium, promoted synaptogenesis in the hippocampus and prefrontal cortex, and improved performance on spatial working memory and long-term memory tasks. Slutsky et al. (2010, also Neuron) confirmed that elevating brain magnesium with MgT enhanced synaptic plasticity, density of dendritic spines, and both short-term and long-term memory in aged rats. These are foundational mechanistic studies; the animal data are high quality and reproducible, but animal-to-human translation of nootropic findings has historically been inconsistent.
2. Cognitive function in aging adults — human RCT (moderate)
Slutsky et al. (2022, Neuron) conducted a double-blind, placebo-controlled trial of 2 g/day Magtein vs. placebo in 109 adults aged 50–70 years over 12 weeks. The primary outcome was composite cognitive ability score derived from neuropsychological testing. The treatment group showed statistically significant improvement on the composite score, and a reversal of approximately 9 years on a brain-age index derived from EEG measures. Secondary measures (working memory, attention, executive function) showed directionally consistent but individually non-significant trends. The study has notable limitations: relatively small sample, industry involvement in design (MIT patent holders), and the composite primary endpoint was constructed post-hoc. Larger, independently-funded trials with preregistered endpoints are needed before strong clinical conclusions can be drawn.
3. Sleep quality — preliminary
Magnesium L-threonate has been reported anecdotally and in some small study analyses to improve sleep quality, possibly via the same NMDA-modulating mechanism that improves sleep with other magnesium forms. It is commonly taken at bedtime. However, no large RCT has established magnesium L-threonate as superior to other magnesium forms specifically for sleep. The sleep signal in the 2022 RCT was a secondary exploratory finding, not a primary outcome.
4. Anxiety — preliminary
Some participants in the 2022 RCT reported reduced anxiety scores, consistent with magnesium's known role in HPA-axis modulation and NMDA receptor inhibition. The anxiety data were exploratory and the trial was not designed or powered to detect anxiety effects. Magnesium bisglycinate or general magnesium repletion has a larger evidence base for anxiety than does the L-threonate form specifically.
Why magnesium L-threonate does not replace a general magnesium supplement
This is the most important practical point about magnesium L-threonate that many product descriptions omit. The 2 g/day Magtein dose delivers approximately 144 mg of elemental magnesium. The RDA for adult men is 400–420 mg/day; for adult women, 310–320 mg/day. A person meeting only half their magnesium needs from diet and relying solely on Magtein would still be approximately 170–280 mg/day short of their RDA.
More to the point, the L-threonate form is optimized for brain delivery, not for correcting systemic magnesium deficiency. If you are magnesium-inadequate and experience muscle cramps, poor sleep, constipation, high blood pressure, or elevated blood glucose, you need higher-dose elemental magnesium from a form like bisglycinate, malate, or citrate. Magtein addresses brain magnesium; it does not efficiently address body magnesium stores.
Magnesium supplement forms compared
| Form | Elemental Mg % | CNS penetrance | Best for | Notes |
|---|---|---|---|---|
| L-Threonate (Magtein) | ~7–8% (144 mg elemental in 2 g dose) | High (brain-targeted) | Cognitive aging, memory, brain Mg | Patented; most expensive form; NOT for general deficiency repletion. |
| Bisglycinate | ~14–17% | Standard | Sleep, anxiety, GI-sensitive users | Best GI tolerability; glycine synergy for sleep/calm. |
| Malate | ~11–15% | Standard | Energy, fibromyalgia, daytime use | Krebs-cycle co-molecule; good tolerability. |
| Taurate | ~8–9% | Standard | Cardiovascular, blood pressure | Taurine pairing for heart/vascular synergy. |
| Citrate | ~16% | Standard | General use, constipation | Good absorption; laxative at higher doses. |
| Oxide | ~60% | Poor (low bioavailability) | Constipation (antacid use) | ~4% absorption; unsuitable for repletion despite high elemental %. |
How much magnesium L-threonate should you take?
- Research dose: 2 g/day of Magtein complex, usually 3 capsules of ~667 mg. This provides approximately 144 mg of elemental magnesium.
- Timing: Most commonly split as 1 capsule in the morning + 2 capsules at bedtime, or all 3 at night. The evening dose is often preferred for concurrent sleep benefits.
- Additional magnesium needed: If you are not meeting your full magnesium RDA (310–420 mg/day) from diet, supplement the deficit with a separate higher-dose magnesium form (e.g., bisglycinate or malate).
- Supplemental UL: The 350 mg/day supplemental Upper Limit applies to total elemental magnesium from all supplement sources, including the 144 mg from Magtein plus any additional magnesium supplements.
Safety, side effects, and considerations
Magnesium L-threonate is well tolerated at the 2 g/day research dose. The 2022 RCT observed headache more frequently in the treatment group during the first two weeks, attributed to initial adjustments in CNS magnesium and neuronal activity. This typically resolves with continued use.
Common side effects
- Headache during the initial 1–2 weeks in some users
- Drowsiness (which can be leveraged for sleep support with evening dosing)
- Mild GI effects possible at higher doses, though the low elemental content makes osmotic laxation unlikely at the standard 2 g/day dose
Kidney disease
The same caution applies as for all magnesium supplements: individuals with advanced CKD (eGFR <30) must not use magnesium supplements without nephrologist supervision due to impaired magnesium excretion.
Cost and value considerations
Magtein is among the most expensive magnesium supplement forms, often 3–5 times the per-dose cost of bisglycinate or malate. At the 2 g/day dose, monthly cost typically runs $40–70 USD. The investment is most defensible for adults in their 50s and beyond seeking cognitive aging support, who are otherwise meeting their full magnesium RDA from diet or separate supplementation.
Drug and nutrient interactions
- NMDA receptor modulators (ketamine, memantine): Magnesium potentiates NMDA antagonism. Theoretical additive CNS effects; discuss with your neurologist or psychiatrist if relevant.
- Quinolone and tetracycline antibiotics: Magnesium chelates these antibiotics; separate doses by 2+ hours.
- Bisphosphonates: Separate by 2+ hours.
- PPIs: Long-term PPI use depletes magnesium; co-supplementation is reasonable, but the 144 mg elemental in Magtein may not be sufficient for repletion.
- Vitamin D: Magnesium is required for vitamin D activation; co-supplementation is mutually beneficial.
- Other magnesium supplements: Count total elemental magnesium from all forms when assessing proximity to the 350 mg supplemental UL.
Check our free interaction checker for additional combinations.
Who might benefit — and who shouldn't bother
| Most likely to benefit | Unlikely to benefit / better alternatives |
|---|---|
| Adults 50+ concerned about cognitive aging and memory | Young, healthy adults without cognitive concerns — evidence does not support prophylactic use |
| Individuals who are already meeting their body magnesium RDA and want targeted brain support | People with general magnesium deficiency (bisglycinate or malate is more appropriate and cost-effective) |
| Those who want an evidence-informed nootropic with mechanistic plausibility and a human RCT | Anyone expecting Magtein to provide the same general-body benefits as other magnesium forms at equivalent elemental doses |
| People with insomnia who want magnesium with a possible cognitive aging co-benefit | Individuals with advanced kidney disease (eGFR <30) without medical supervision |
Frequently asked questions
Does magnesium L-threonate improve memory?
The 2022 Slutsky RCT (n=109, age 50–70) showed statistically significant improvements on a composite cognitive score and a reversal of approximately 9 years on a brain-age EEG index over 12 weeks. The results are promising but come from a single, relatively small trial with involvement from the patent holders. Larger independent trials are needed. The animal evidence (Liu 2010, Slutsky 2010) is mechanistically strong — the human translation is plausible but not yet confirmed at scale.
Is Magtein worth the extra cost?
That depends on your goal. For general magnesium repletion, bisglycinate or malate are far more cost-effective and deliver more elemental magnesium. For cognitive aging support specifically, Magtein is the only form with a mechanism-supported rationale and a human RCT. Whether a modest cognitive benefit over 12 weeks in a 109-person trial justifies the premium cost is a personal decision that should incorporate your age, cognitive concerns, and budget.
Can magnesium L-threonate fix a magnesium deficiency?
No. The 2 g/day Magtein dose delivers only ~144 mg of elemental magnesium — well below the adult RDA of 310–420 mg/day. If you are magnesium-deficient, use a higher-dose form (bisglycinate, malate, or citrate) providing 200–350 mg elemental/day from supplements. You can take Magtein for cognitive support alongside a separate magnesium supplement for deficiency, as long as total supplemental elemental magnesium remains within the 350 mg/day UL.
What is the correct Magtein dose?
The dose used in published research is 2 g/day of the Magtein complex, typically 3 capsules of ~667 mg each (or equivalent formulations). This delivers ~144 mg elemental magnesium. Some practitioners split this as 1 capsule with breakfast and 2 at bedtime; others take all 3 at night. Do not take more than 2 g/day without medical supervision.
Is magnesium L-threonate the same as magnesium threonate?
Yes — they are the same compound. "Magnesium L-threonate" is the technically precise name (specifying the L-enantiomer of threonic acid). "Magnesium threonate" is the generic label many supplements use. "Magtein" is the branded, patented form from Magceutics/Life Extension. Products labeled "magnesium threonate" without the Magtein mark may use an unbranded version of the same chemistry; quality can vary. See also: our separate page on magnesium threonate (generic).
Does magnesium L-threonate cause headaches?
The 2022 RCT observed headache more commonly in the active-supplement group during the first two weeks, thought to reflect the initial increase in CNS magnesium and consequent shifts in NMDA receptor activity and neuronal excitability. Most users report this is transient. Starting with 1 capsule/day and gradually increasing to the full 2 g/day dose may reduce this effect.
Quick facts
| Category | Minerals · Brain Magnesium |
|---|---|
| Primary use | Cognitive |
| Common forms | Capsule |
| Also known as | Magtein |
| U.S. regulatory status | GRAS |
Related ingredients and articles
Magnesium Threonate (generic)
The same L-threonate chemistry without the Magtein brand name.
Magnesium Bisglycinate
Best-tolerated form for sleep, anxiety, and general magnesium repletion.
Magnesium Taurate
Cardiovascular-focused magnesium with taurine pairing.
Best Magnesium Supplement (2026)
How to choose the right form for your specific goal.
Disclaimer: This information is for educational purposes only and should not replace medical advice. Always consult a qualified healthcare provider before starting any supplement, especially if you have a medical condition, are pregnant, or take prescription medications. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.